LifeArc
Overview
LifeArc is a self-funded medical research charity and investment firm that translates early-stage science into healthcare treatments and diagnostics, with a venture arm that invests in therapeutics and medtech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AviadoBio | Dec 2021 | Series A | Co-investor |
| Oxford Drug Design | Sep 2024 | Grant | Co-investor |
| Cumulus Neuroscience | May 2021 | Series A | Co-investor |
| Glox Therapeutics | Jan 2025 | Grant | Co-investor |
| Pheno Therapeutics | Feb 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Catherine Briggs
Reward and Benefits Partner
Andrew Gerard Cairns
Principal Scientist
Beth Wensley
Principal Scientist - Protein Sciences
Carolyn Clarke
Principal Scientist
Chris Coward
Principal Research Scientist
Colin Robinson
Principal Scientist
David McCoull
Principal Scientist
David P.
Principal Scientist
Debra Taylor
Senior Principal Scientist, Drug Discovery Manager
Ed M.
Principal Machine Learning Scientist
Kristian Birchall
Principal Scientist
Martina Trokter
Principal Scientist
Natasha Ratcliffe
Principal, Patient Engagement
Rachel Forfar
Principal Scientist
Rodrigo Abreu
Principal Scientist
Sandra Kümper
Principal Scientist and Team Leader Chemical Biology
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LifeArc based?
LifeArc is headquartered in London, United Kingdom.
When was LifeArc founded?
LifeArc was founded in 2000.
How many portfolio companies does LifeArc have?
LifeArc has 23 portfolio companies in Caplight's dataset.
What are some companies in LifeArc's portfolio?
Portfolio companies visible on Caplight include AviadoBio, Oxford Drug Design, Cumulus Neuroscience, Glox Therapeutics, Pheno Therapeutics.
What was LifeArc's most recent investment shown here?
LifeArc's most recent investment in this portfolio sample was in Glox Therapeutics in 2025.
What sectors does LifeArc focus on?
LifeArc focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does LifeArc focus on?
LifeArc typically invests at the Early stage.
What is LifeArc's AUM?
LifeArc's assets under management are estimated between $1.0B and $10.0B.